Table 2.
Outcomes.
| Outcomes related to the blood pressure and oxygenation-interventions | Outcomes associations with central hemodynamics |
|---|---|
| Cardiac output* | All-cause mortality until day 180 |
| Cardiac power index (MAP*cardiac index (CI)/451 W/m2) | Renal replacement therapy |
| Pulmonary vascular pressures (mean, systolic, diastolic) | Neuron-Specific Enolase (NSE) level at 48 hours |
| Central venous pressure (mean) | Montreal Cognitive Assessment (MoCA) score at three months (lowest score allocated to patients not available for follow-up) |
| Pulmonary capillary wedge pressure | Modified Ranking Scale (mRS) at 3 months |
| Systemic vascular resistance* | NT-pro-BNP at 48 hours |
| Pulmonary vascular resistance* | LVEF at last available measurement |
| Mixed venous oxygen saturation and arterial-venous oxygen difference | Cumulated vasopressor requirement |
| Tricuspid annular plane systolic excursion (TAPSE) | Creatinine-clearance at 48 hours |
| Left Ventricular Ejection Fraction | Urinary output per day |
| Pulse-pressure (MAP-CVP) | Interleukin-6 at 48 hours |
| Arterial elastance | lactate |
| Lactate clearance |
*
and corresponding indexed values (related to body-surface area).